A federal judge has posed some pointed questions for a hearing Wednesday where he will consider whether to grant preliminary approval to a Bayer-proposed settlement for a so-called “futures class” of plaintiffs who contract non-Hodgkin lymphoma.
Shining Light on Farm & Food Policy for 20 Years.
Friday, April 19, 2024